MWNA
EOLS icon

Marshall Wace North America’s Evolus EOLS Stock Holding History

Marshall Wace North America’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$316K Sell
41,439
-328,601
-89% -$3.4M ﹤0.01% 1228
2021
Q2 		$4.68M Buy
370,040
+335,394
+968% +$3.69M 0.02% 566
2021
Q1 		$449K Buy
+34,646
New +$319K ﹤0.01% 1229
2018
Q4 		– Sell
-242,278
Closed -$4.51M – 1516
2018
Q3 		$4.51M Buy
+242,278
New +$5.25M 0.03% 339

Other funds holding EOLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $146M AUM 71.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's EOLS Position: Q3 2021 in Review

Marshall Wace North America reduced its Evolus (EOLS) stake by 89% in Q3 2021, selling an estimated $3.4M and leaving 41,439 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1228.

Marshall Wace North America first reported a position in EOLS in Q3 2018 and has held it in 4 quarters since. The position peaked at $4.68M in Q2 2021. 113 funds tracked by Wall St. Rank hold EOLS as of Q3 2021.

  • Marshall Wace North America held 41,439 shares of Evolus worth $316K as of Q3 2021.
  • Marshall Wace North America sold 328,601 Evolus shares in Q3 2021, an estimated $3.4M.
  • Evolus made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1228 holding.
  • Marshall Wace North America first reported a position in Evolus in Q3 2018 and has held it in 4 quarters since.
  • Marshall Wace North America's Evolus position peaked at $4.68M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Evolus as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.